Kay carried out her PhD at the University of Edinburgh. She has an interest in host pathogen interactions and before joining the team her research focused on the immune response to avian and zoonotic pathogens using a variety of molecular and histological techniques.
Kay enjoys working in translational research. She joined the THT Group in 2019 to support the development of a pneumococcal human infection study. She has since become involved in various projects to support the progress of the devices and Smartprobes.
FluoroPi Device With SmartProbes: A Frugal Point-of-Care System for Fluorescent Detection of Bacteria From a Pre-Clinical Model of Microbial Keratitis (2023)
Mohanan SMPC, Russell K, Duncan S, Kiang A, Lochenie C, Duffy E, Kennedy S, Prajna NV, Williams RL, Dhaliwal K, Williams GOS, Mills B.
Randomised Controlled Trial of Intravenous Nafamostat Mesylate in COVID pneumonitis: Phase 1b/2a Experimental Study to Investigate Safety, Pharmacokinetics and Pharmacodynamics (2022).
Quinn T, Gaughan E E, Bruce A, Antonelli J, O’Connor R A, Li F, McNamara S, Koch O, Mackintosh C, Dockrell D, Walsh T, Blyth K G, Church C, Schwarze J, Boz C, Valanciute A, Burgess M, Emanuel P, Mills B, Rinaldi G, Hardisty G, Mills R, Findlay EG, Jabbal S, Duncan A, Plant S, Marshal ADL, Young I, Russell K, Scholefield E, Nimmo AF, Nazarov IB, Churchill GC, McCullagh JSO, Ebrahimi KH, Ferrett C, Templeton K, Rannard S, Owen A, Moore A, Finlayson K, Shankar-Hari M, Norrie J, Parker RA, Akram AR, Anthony DC, Dear JW, Hirani N, Dhaliwal K.